How to Choose a GLP-1 Provider: A Six-Point Checklist

The medication is not the hard part anymore. The provider is. Two people can take the exact same molecule and have wildly different experiences depending on who prescribes it, what they pay, and what happens when a side effect shows up. This checklist scores the provider — not the drug — using the same six dimensions we grade every company on.

The molecule works; the provider is the variable

The trial record on GLP-1 weight management is strong and specific. Once-weekly semaglutide 2.4 mg produced a mean body-weight change of about −14.9% over 68 weeks in the STEP-1 trial¹, and tirzepatide reached up to roughly −20.9% at 72 weeks in SURMOUNT-1². Those numbers come from tightly run studies with real clinical supervision. A telehealth provider is the layer between that evidence and your kitchen counter — and that layer is where quality actually varies. Grade it deliberately.

The six dimensions we score

Our WeighScore methodology runs every provider through the same rubric, weighted like this:

Cost value (25%), dose and formulation (20%), clinical oversight (20%), labs and monitoring (15%), fulfillment (12%), and contract terms (8%). Use the same six as your personal checklist. Here is what each one really means when you are the one paying.

1. Normalize the price before you compare it

The headline number is almost never the number you pay in month four. Introductory pricing, dose-based step-ups, and "membership plus medication" splits make two providers that look identical on the landing page diverge by hundreds of dollars once you titrate up. Convert every offer to a single figure: total dollars per month at your expected maintenance dose, after any intro period ends. Our breakdown of what compounded GLP-1 costs per month shows how to do that conversion, and if insurance is part of your math, see does insurance cover GLP-1 weight-loss drugs? before you assume any quoted price is what you'll actually pay.

2. Check what molecules and doses are on the menu

A provider that only stocks one molecule at two doses cannot follow you if your body needs to switch or titrate differently. Look for both semaglutide and tirzepatide, a full titration ladder, and clarity on formulation (injectable vs. oral or sublingual). If you are still deciding which drug to ask about, start with semaglutide vs. tirzepatide.

3. Confirm there is real clinical oversight

You want a licensed prescriber who reviews your history, not a rubber-stamp intake form. Ask: Who signs the prescription? Can you reach a clinician between visits? What is the escalation path if you have a serious side effect? A provider that cannot answer those in plain language loses points on the dimension that matters most for safety. Very few clear the bar in both directions: The Edit names both its prescriber and its pharmacy, and publishes an NPI you can look up, which is more than most of the market manages. A real intake should also be screening for the specific risks the trials and FDA labels actually document — see our full breakdown of GLP-1 side effects — and asking about factors like heavy alcohol use, where the evidence is newer than most providers realize.

4. Ask whether labs and monitoring are included

Baseline labs, periodic check-ins, and structured side-effect monitoring are either built into the program or bolted on at extra cost — and the difference changes both your safety and your true price. A program that "includes monitoring" but never actually checks in is scoring on paper only. Pin down the cadence — it matters especially because, as the weight-regain evidence shows, this is a long-term relationship, not a one-time prescription.

5. Interrogate fulfillment and sourcing

Where does the drug come from, and can they tell you? Brand-name products are FDA-approved and dispensed from the manufacturer's supply chain; compounded products come from 503A pharmacies or 503B outsourcing facilities under a different framework. Understand which you are getting before you buy — see compounded vs. brand-name GLP-1 and, if you are considering compounded, is compounded semaglutide legit and safe? A provider using the 503B pathway is only on solid legal ground while that specific drug sits on the FDA's shortage list — see why compounded GLP-1's legality hinges on the FDA shortage list for the mechanism, and be ready to ask about it directly. Most sellers answer this question with a phrase like "an FDA-registered U.S. pharmacy" and nothing further, which is why the exceptions are worth knowing about: Pallas Health names six dispensing pharmacies outright and explains the 503A/503B split on the same page. That disclosure is also what makes the follow-up question answerable — one of the six drew an FDA warning letter in March 2023 that the agency closed out in October 2023 — and you can only look that up once a provider has told you who fills your prescription.

6. Read the contract before the first charge

Cancellation friction, refund posture, auto-renewal honesty, and lock-in are where good-looking offers quietly go bad. Find the cancel button before you subscribe. If you cannot locate the terms, or they require a phone call to escape, treat that as a scored weakness — not a formality. Watch for the softer version too, where the terms are fine but the price you are shown is not the one on offer without a commitment — our review of MyDrHank walks through a site whose own FAQ calls a twelve-month prepay rate a plan with "no contract", and which advertises one tirzepatide price that is purchasable at no tier at all.

The 60-second scorecard

Before you enter a card number, you should be able to answer, in one sentence each: what you pay per month at maintenance; which molecules and doses are available; who your prescriber is and how to reach them; whether labs and monitoring are included; where the medication is sourced; and how you cancel. Six clean answers means a provider worth grading highly. Any blanks are the provider's problem to fix, not yours to excuse — and some companies make the first answer impossible to give. Lighter You is the sharpest example we have found: its whole public price surface is seven hardcoded strings, the headline figure among them matches no program on the site, and every route to a real number is behind a login.

Where to start

Rather than guess, compare graded providers side by side. Browse the full provider reviews and head-to-head comparisons, or start with our current top-graded provider, CoreAge Rx. If one constraint dominates, jump straight to it: the tirzepatide scorecard for the molecule, or the cheapest GLP-1 ledger for the budget. Every grade uses the same formula — the six weighted factors and the score-to-letter cutoffs are laid out in how the WeighScore is calculated. Assume any provider we list may compensate us — it never moves the number, and it never softens what we write about the provider behind it. That commitment is written down rather than implied: see our editorial policy for the rules, and about for who applies them.